The soluble form of this receptor, sCD163, is a byproduct of TNF-α converting enzyme (TACE), also involved in the release of TNF-α (which holds a major role in the pathophysiology of RA) [36]. This evidence concerns the gene TNF and rheumatoid arthritis.